FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dani Bolognesi

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Neutralization Tests

Disorders

Co-author Network

Publications

TOP 3
Tom Matthews; Miklos Salgo; Michael Greenberg; Jain Chung; Ralph DeMasi; Dani P Bolognesi
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes.
Dani P Bolognesi
Basic science in a department of surgery.
Celia C LaBranche; G Galasso; JP Moore; Dani P Bolognesi; M S Hirsch; S M Hammer
HIV fusion and its inhibition.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dani Bolognesi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Tom Matthews; Miklos Salgo; Michael Greenberg; Jain Chung; Ralph DeMasi; Dani P Bolognesi
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes.
Nature reviews. Drug discovery 2004;3(3):215-25.
2003: Dani P Bolognesi
Basic science in a department of surgery.
Annals of surgery 2003;238(6 Suppl):S33.
2001: Celia C LaBranche; G Galasso; JP Moore; Dani P Bolognesi; M S Hirsch; S M Hammer
HIV fusion and its inhibition.
Antiviral research 2001;50(2):95-115.
2000: M Juliana McElrath; Lawrence Corey; David Montefiori; Mark Wolff; David H Schwartz; Michael C Keefer; Robert B Belshe; Barney S Graham; T Matthews; P Wright; Geoffrey J Gorse; Raphael Dolin; Phillip W. Berman; D Francis; AM Duliege; Dani P Bolognesi; Donald Stablein; N Ketter; Patricia Fast
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.
AIDS research and human retroviruses 2000;16(9):907-19.
2000: M Louise Markert; Charles B Hicks; John A Bartlett; J L Harmon; Laura P Hale; ML Greenberg; Guido Ferrari; Janet Ottinger; A Boeck; A L Kloster; TM McLaughlin; KAREN BLEICH; R M Ungerleider; H Kim Lyerly; William E Wilkinson; Franck Rousseau; ME Heath-Chiozzi; JM Leonard; Ashley T Haase; George M Shaw; R Pat Bucy; D C Douek; Richard A Koup; Barton F Haynes; Dani P Bolognesi; Kent J Weinhold
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.
AIDS research and human retroviruses 2000;16(5):403-13.
1998: J. Michael Kilby; S Hopkins; T M Venetta; B DiMassimo; Gretchen A Cloud; J Y Lee; L Alldredge; Eric Hunter; D Lambert; Dani P Bolognesi; Tom Matthews; M R Johnson; M A Nowak; George M Shaw; Michael S Saag
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
Nature medicine 1998;4(11):1302-7.
1998: Douglas S Tyler; S D Stanley; John A Bartlett; Dani P Bolognesi; Kent J Weinhold
Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.
The Journal of surgical research 1998;79(2):115-20.
1998: A J Langlois; Ronald C Desrosiers; M G Lewis; V N KewalRamani; Dan R Littman; JY Zhou; Kelledy Manson; Michael S Wyand; Dani P Bolognesi; David C Montefiori
Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus.
Journal of virology 1998;72(8):6950-5.
1998: David C Montefiori; Keith A Reimann; Michael S Wyand; Kelledy Manson; M G Lewis; R G Collman; Joseph Sodroski; Dani P Bolognesi; Norman L Letvin
Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.
Journal of virology 1998;72(4):3427-31.
1998: David C Montefiori; R G Collman; T R Fouts; JY Zhou; Miroslawa Bilska; James A Hoxie; JP Moore; Dani P Bolognesi
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.
Journal of virology 1998;72(3):1886-93.
1997: A K Pilgrim; G Pantaleo; O J Cohen; L M Fink; JY Zhou; J T Zhou; Dani P Bolognesi; Anthony Fauci; David C Montefiori
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.
The Journal of infectious diseases 1997;176(4):924-32.
1997: Dani P Bolognesi
HIV. A clever hijacker of the immune system.
Current opinion in immunology 1997;9(4):549-50.
1997: Guido Ferrari; W Humphrey; M Juliana McElrath; Jean-Louis Excler; AM Duliege; M L Clements; Lawrence Corey; Dani P Bolognesi; Kent J Weinhold
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(4):1396-401.
1997: ML Greenberg; SF Lacey; Chin Ho Chen; Dani P Bolognesi; Kent J Weinhold
Noncytolytic CD8 T cell-mediated suppression of HIV replication.
Springer seminars in immunopathology 1997;18(3):355-69.
1995: G Ferrari; K King; K Rathbun; C A Place; M V Packard; John A Bartlett; Dani P Bolognesi; Kent J Weinhold
IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
Clinical and experimental immunology 1995;101(2):239-48.
1995: C H Chen; TJ Matthews; C B McDanal; Dani P Bolognesi; ML Greenberg
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion.
Journal of virology 1995;69(6):3771-7.
1995: P M Ahearne; R A Morgan; Mark W Sebastian; Dani P Bolognesi; Kent J Weinhold
Multiple CTL specificities against autologous HIV-1-infected BLCLs.
Cellular immunology 1995;161(1):34-41.
1994: Michael C Keefer; Barney S Graham; Robert B Belshe; David H Schwartz; Lawrence Corey; Dani P Bolognesi; Donald Stablein; D C Montefiori; M Juliana McElrath; M L Clements
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.
AIDS research and human retroviruses 1994;10(12):1713-23.
1994: Robert B Belshe; Barney S Graham; Michael C Keefer; Geoffrey J Gorse; P Wright; Raphael Dolin; T Matthews; Kent J Weinhold; Dani P Bolognesi; R Sposto
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
JAMA : the journal of the American Medical Association 1994;272(6):475-80.
1994: TJ Matthews; C Wild; C H Chen; Dani P Bolognesi; ML Greenberg
Structural rearrangements in the transmembrane glycoprotein after receptor binding.
Immunological reviews 1994;140():93-104.
1994: G Ferrari; C A Place; P M Ahearne; S M Nigida; Larry O Arthur; Dani P Bolognesi; Kent J Weinhold
Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees.
Journal of acquired immune deficiency syndromes 1994;7(4):325-31.
1994: K Javaherian; A J Langlois; D C Montefiori; K A Kent; K A Ryan; P D Wyman; J Stott; Dani P Bolognesi; Michael Murphey-Corb; Greg La Rosa
Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein.
Journal of virology 1994;68(4):2624-31.
1993: C H Chen; Kent J Weinhold; John A Bartlett; Dani P Bolognesi; ML Greenberg
CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.
AIDS research and human retroviruses 1993;9(11):1079-86.
1993: Barton F Haynes; José V Torres; A J Langlois; Dani P Bolognesi; Murray B Gardner; TJ Palker; Richard M Scearce; D M Jones; M Anthony Moody; C McDanal
Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(3):1646-53.
1993: Dani P Bolognesi
The immune response to HIV: implications for vaccine development.
Seminars in immunology 1993;5(3):203-14.
1993: Barney S Graham; TJ Matthews; Robert B Belshe; M L Clements; Raphael Dolin; Peter F Wright; Geoffrey J Gorse; David H Schwartz; Michael C Keefer; Dani P Bolognesi
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.
The Journal of infectious diseases 1993;167(3):533-7.
1993: Dani P Bolognesi
Human immunodeficiency virus vaccines.
Advances in virus research 1993;42():103-48.
1993: Barton F Haynes; Y Yasutomi; José V Torres; Murray B Gardner; A J Langlios; Dani P Bolognesi; TJ Matthews; Richard M Scearce; D M Jones; M Anthony Moody
Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
Transactions of the Association of American Physicians 1993;106():33-41.
1992: C Wild; Terrence G Oas; C McDanal; Dani P Bolognesi; T Matthews
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(21):10537-41.
1992: A J Langlois; Kent J Weinhold; TJ Matthews; ML Greenberg; Dani P Bolognesi
Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus.
AIDS research and human retroviruses 1992;8(9):1641-52.
1992: K Javaherian; A J Langlois; S Schmidt; M Kaufmann; N Cates; J P Langedijk; R H Meloen; R C Desrosiers; D P Burns; Dani P Bolognesi
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(4):1418-22.
1992: A J Langlois; Kent J Weinhold; TJ Matthews; ML Greenberg; Dani P Bolognesi
The ability of certain SIV vaccines to provoke reactions against normal cells.
Science (New York, N.Y.) 1992;255(5042):292-3.
1991: Dani P Bolognesi
Perspectives on the development of anti-HIV vaccines.
Current opinion in biotechnology 1991;2(6):893-6.
1991: Greg La Rosa; K Weinhold; A T Profy; A J Langlois; G R Dreesman; R N Boswell; P Shadduck; Dani P Bolognesi; TJ Matthews; E A Emini
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications.
Science (New York, N.Y.) 1991;253(5024):1146.
1991: K C Stine; Douglas S Tyler; S D Stanley; John A Bartlett; Dani P Bolognesi; Kent J Weinhold
The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.
Cellular immunology 1991;136(1):165-72.
1991: A J Langlois; Kent J Weinhold; TJ Matthews; Dani P Bolognesi
In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251.
AIDS research and human retroviruses 1991;7(8):713-20.
1991: P P Shadduck; J Brice Weinberg; Arthur F Haney; John A Bartlett; A J Langlois; Dani P Bolognesi; TJ Matthews
Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.
Journal of virology 1991;65(8):4309-16.
1991: Dani P Bolognesi
HIV vaccine development: perspective.
Biotechnology therapeutics 1991;2(1-2):205-11.
1991: TJ Matthews; A J Langlois; S Butto; Dani P Bolognesi; K Javaherian
HIV-1 neutralizing antibody and approaches to the envelope diversity problem.
Advances in experimental medicine and biology 1991;303():23-6.
1990: K Javaherian; A J Langlois; Greg La Rosa; A T Profy; Dani P Bolognesi; W C Herlihy; S D Putney; TJ Matthews
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.
Science (New York, N.Y.) 1990;250(4987):1590-3.
1990: Douglas S Tyler; S D Stanley; Susan Zolla-Pazner; M K Gorny; P P Shadduck; A J Langlois; TJ Matthews; Dani P Bolognesi; TJ Palker; Kent J Weinhold
Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(10):3276-82.
1990: M K Hart; TJ Palker; TJ Matthews; A J Langlois; N W Lerche; M E Martin; Richard M Scearce; C McDanal; Dani P Bolognesi; Barton F Haynes
Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(8):2677-85.
1990: Dani P Bolognesi
Vaccine development for HIV infection.
Journal of the American Academy of Dermatology 1990;22(6 Pt 2):1295-9.
1990: Douglas S Tyler; S D Stanley; C A Nastala; A A Austin; John A Bartlett; K C Stine; H Kim Lyerly; Dani P Bolognesi; Kent J Weinhold
Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(9):3375-84.
1990: Dani P Bolognesi; G C Schild
AIDS 1990. Vaccines and immunology: overview.
AIDS (London, England) 1990;4 Suppl 1():S127-8.
1990: S D Putney; J Rusche; K Javaherian; T Matthews; Dani P Bolognesi
Structural and functional features of the HIV envelope glycoprotein and considerations for vaccine development.
Biotechnology (Reading, Mass.) 1990;14():81-110.
1990: Dani P Bolognesi
Progress in vaccine development against SIV and HIV.
Journal of acquired immune deficiency syndromes 1990;3(4):390-4.
1989: Dani P Bolognesi
Progress in vaccines against AIDS.
Science (New York, N.Y.) 1989;246(4935):1233-4.
1989: K C Stine; Dani P Bolognesi; Kent J Weinhold
Cytokine augmentation of human immunodeficiency virus type 1 (HIV-1) gp120-specific cellular cytotoxicity.
Journal of biological response modifiers 1989;8(5):501-10.
1989: K Javaherian; A J Langlois; C McDanal; K L Ross; L I Eckler; C L Jellis; A T Profy; J R Rusche; Dani P Bolognesi; S D Putney
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(17):6768-72.
1989: Dani P Bolognesi
Prospects for prevention of and early intervention against HIV.
JAMA : the journal of the American Medical Association 1989;261(20):3007-13.
1989: TJ Palker; TJ Matthews; A Langlois; M E Tanner; M E Martin; Richard M Scearce; J E Kim; J A Berzofsky; Dani P Bolognesi; Barton F Haynes
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(10):3612-9.
1989: Kent J Weinhold; H Kim Lyerly; S D Stanley; A A Austin; TJ Matthews; Dani P Bolognesi
HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(9):3091-7.
1989: Douglas S Tyler; C L Nastala; S D Stanley; TJ Matthews; H Kim Lyerly; Dani P Bolognesi; Kent J Weinhold
GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(4):1177-82.
1989: Dani P Bolognesi
Immunobiology of the HIV envelope.
Annals of the New York Academy of Sciences 1989;567():69-81.
1989: Dani P Bolognesi
HIV antibodies and vaccine design.
AIDS (London, England) 1989;3 Suppl 1():S111-8.
1988: M A Skinner; A J Langlois; C B McDanal; J S McDougal; Dani P Bolognesi; TJ Matthews
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
Journal of virology 1988;62(11):4195-200.
1988: R W Buckheit; Dani P Bolognesi; Kent J Weinhold
The role of bone marrow and thymic elements in the initiation and spread of virus production in the AKR thymus.
Virology 1988;166(2):533-41.
1988: S Chaffee; J M Leeds; TJ Matthews; Kent J Weinhold; M Skinner; Dani P Bolognesi; Michael S Hershfield
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines.
The Journal of experimental medicine 1988;168(2):605-21.
1988: Dani P Bolognesi
Natural immunity to HIV and its possible relationship to vaccine strategies.
Microbiological sciences 1988;5(8):236-41.
1988: P M Ahearne; TJ Matthews; H Kim Lyerly; G C White; Dani P Bolognesi; Kent J Weinhold
Cellular immune response to viral peptides in patients exposed to HIV.
AIDS research and human retroviruses 1988;4(4):259-67.
1988: Kent J Weinhold; H Kim Lyerly; TJ Matthews; Douglas S Tyler; P M Ahearne; K C Stine; A J Langlois; D T Durack; Dani P Bolognesi
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.
Lancet 1988;1(8591):902-5.
1988: TJ Palker; M E Clark; A J Langlois; TJ Matthews; Kent J Weinhold; Richard R Randall; Dani P Bolognesi; Barton F Haynes
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(6):1932-6.
1988: A J Langlois; TJ Matthews; Kent J Weinhold; S Chaffee; Michael S Hershfield; Dani P Bolognesi
Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay.
AIDS research and human retroviruses 1988;4(1):63-9.
1988: R W Buckheit; J Kurtzberg; Dani P Bolognesi; Kent J Weinhold
The coenrichment of stem cells, prothymocytes, and stromal elements with ecotropic retrovirus-producing cells from the bone marrow of leukemia-prone AKR mice.
Virology 1988;162(2):354-61.
1988: R W Buckheit; S N Liberman; Dani P Bolognesi; Kent J Weinhold
The effects of leukemosuppressive immunotherapy on thymic infectious cell centers in AKR mice.
Thymus 1988;12(3):143-56.
1988: K Thiel; E V Genovesi; J Dirk Iglehart; Dani P Bolognesi; Kent J Weinhold
Loss of tumorigenicity following in vitro MuLV infection is associated with induction of peritoneal natural killer cell activity.
Advances in experimental medicine and biology 1988;239():169-83.
1987: J R Rusche; D L Lynn; M Robert-Guroff; A J Langlois; H Kim Lyerly; H Carson; K Krohn; A Ranki; Robert C Gallo; Dani P Bolognesi
Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(19):6924-8.
1987: TJ Palker; TJ Matthews; M E Clark; G J Cianciolo; Richard R Randall; A J Langlois; G C White; B Safai; R Snyderman; Dani P Bolognesi
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(8):2479-83.
1987: TJ Matthews; A J Langlois; W G Robey; N T Chang; Robert C Gallo; P J Fischinger; Dani P Bolognesi
Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein.
Haematology and blood transfusion 1987;31():414-22.
1987: TJ Matthews; H Kim Lyerly; Kent J Weinhold; A J Langlois; J Rusche; S D Putney; Robert C Gallo; Dani P Bolognesi
Prospects for development of a vaccine against HTLV-III-related disorders.
AIDS research and human retroviruses 1987;3 Suppl 1():197-206.
1986: A J Nahmias; J Weiss; X Yao; F Lee; R Kodsi; M Schanfield; T Matthews; Dani P Bolognesi; D Durack; A Motulsky
Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.
Lancet 1986;1(8492):1279-80.
1984: TJ Palker; Richard M Scearce; S E Miller; M Popovic; Dani P Bolognesi; Robert C Gallo; B F Haynes
Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV.
The Journal of experimental medicine 1984;159(4):1117-31.
1982: E C Ward; J Dirk Iglehart; K J Weinhold; Dani P Bolognesi
Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
Journal of the National Cancer Institute 1982;69(2):509-15.
1981: J Dirk Iglehart; E C Ward; G Huper; K Thiel; Dani P Bolognesi
In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
Journal of the National Cancer Institute 1981;67(1):117-22.
1981: J Dirk Iglehart; E C Ward; K Thiel; G Huper; S S Geier; Dani P Bolognesi
In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
Journal of the National Cancer Institute 1981;67(1):107-15.
1981: J Dirk Iglehart; Kent J Weinhold; G Huper; K Thiel; Dani P Bolognesi
In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Journal of the National Cancer Institute 1981;67(1):123-30.